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ABSTRACT Formation of heteromeric complexes between voltage-gated K1 (Kv) channels and accessory (b) subunits is a
widespread means to generate heterogeneity of K1 current in the nervous system. Here we investigate the principles that
determine the interactions of Caenorhabditis elegans MPS-1, a bifunctional b-subunit that possesses kinase activity, with Kv
channels. MPS-1 belongs to the evolutionarily conserved family of KCNE b-subunits that modulate the functional properties of a
variety of Kv channels and that, when defective, can cause congenital and acquired disease inHomo sapiens. In Chinese hamster
ovary cells, MPS-1 forms stable complexes with different a-subunits. The transmembrane domain of MPS-1 is necessary and
sufﬁcient for MPS-1 complex formation. The hydropathicity of the transmembrane domain is an important factor controllingMPS-1
assembly. A highly hydrophobic MPS-1 mutant fails to interact with its endogenous channel partners when transgenically
expressed in living worms. The hydropathic mechanism does not require speciﬁc points of contact between interacting proteins.
This may allow MPS-1 to assemble with various Kv channels, presumably modifying the electrical properties of each.
INTRODUCTION
Voltage-dependent potassium (K1) channels (Kv) regulate
neuronal excitability by controlling the movement of K1
ions across the membrane in response to changes in the cell
voltage. Generally, Kv channels contain additional regula-
tory proteins or b-subunits that modulate their properties,
including permeation, gating, trafﬁcking, location and abun-
dance, sensitivity to stimulation, and pharmacology (1).
Thus, b-subunits may represent a widespread means to gen-
erate heterogeneity of K1 current in biological organisms.
An example of this process isCaenorhabditis elegansMPS-1,
a b-subunit that partners with Kv channel KVS-1 to form a
complex that is necessary for the normal neuronal function of
the animal (2). MPS-1 is a small integral membrane protein
with a single transmembrane span. It also possesses a cat-
alytic domain that acts to phosphorylate KVS-1 and other
substrates (3). Functional studies have shown that MPS-1
has the ability to control KVS-1 function through indepen-
dent mechanisms that stem from its b-subunit and protein
kinase dual nature (3). Phylogenetically, mps-1 belongs to
the family of kcne genes that operate in invertebrates, am-
phibians, and mammals including Homo sapiens (4–7). In
humans there are ﬁve kcne genes; genetic mutations in three
of them are linked to congenital and acquired disease (4,8–
11). A well-established characteristic of KCNE proteins is
the ability to assemble with multiple pore-forming subunits
(12,13). This feature makes the study of KCNE proteins
particularly signiﬁcant from a biomedical point of view for
the potential impact that a defective kcne gene can have on
multiple currents (14). MPS-1 is expressed in—and is nec-
essary for the normal function of—neurons where KVS-1 is
absent (2). This argues that MPS-1 must partner with several,
presently unidentiﬁed, Kv channels in the nervous system of
C. elegans. Thus, the bifunctional nature of MPS-1, together
with its putative promiscuous partnering behavior, makes
this protein a potentially powerful mediator to generate hete-
rogeneity of neuronal K1 currents.
The tools available for genetic manipulation of C. elegans
allow in vivo testing of models elaborated in heterologous ex-
pression systems. Toward this end, we use the MPS-1-KVS-1
channel complex as a system to investigate the principles that
govern the assembly of MPS-1 witha-subunits. Here we show
that the hydropathicity of the transmembrane domain (TMD)
of MPS-1 plays an important role in determining its interac-
tions with a-subunits in vivo and in vitro. This domain con-
tains several polar residues that may act to decrease its stability
in the cell membrane. We propose a model that predicts that
one of the forces drivingMPS-1 assembly stems from the need
to minimize the electrostatic energy associated with the pres-
ence of polar residues embedded in the lipid. Thus, being
surrounded by other proteins rather than lipids may increase
the stability of MPS-1. This mechanism is consistent with pro-
miscuous assembly of MPS-1 because it would not require
speciﬁc points of contact between TMDs, a condition almost
impossible to fulﬁll with distinct channels. Thus, simple di-
electric forces may allow MPS-1 to generate K1 current het-
erogeneity through multiple partnerships by means of both its
b-subunit nature and its enzymatic activity.
METHODS AND MATERIALS
Molecular biology
MPS-1 mutants were constructed by polymerase chain reaction (PCR). M1-
DN was obtained by deleting the ﬁrst 41 amino acids and by placing a
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methionine before E42. M1-DC was obtained by inserting a stop codon after
R70. Thus, M1-DN and M1-DC had, respectively, three and four residues
left before/after the TMD. M1-TM was obtained by placing a methionine
before D25 and a stop codon after E94. MPS-1, wild-type, and truncation
mutants MPS-3, KVS-1, and human Kv4.2 were epitope tagged in the
C-terminus by replacing the terminal stop codon with nucleotides encoding
HA residues (YPYDVPDYA-STOP) or c-Myc residues (ISMEQKLI-
SEEDLN). To insert the epitope tags in the N-terminus, a methionine was
added in front of the HA or c-Myc sequences, which were fused in frame
with the ﬁrst methionine of MPS-1. The constructs were subcloned into
pCI-neo vector (Promega, Madison, WI) for expression in CHO cells. An
;4.5 kb insert of genomic DNA containing the unspliced sequence ofmps-1
and its promoter sequence was inserted into the Fire vector pPD95.75 (1995
Fire Vector Kit) in frame with the gfp gene. This construct was used as a
template to generate the mps-1-Q mutant by PCR. All sequences were
conﬁrmed by automated DNA sequencing. Transcripts were quantiﬁed with
spectroscopy and compared with control samples separated by agarose gel
electrophoresis stained with ethidium bromide.
Biochemistry
Immunoprecipitations and coimmunoprecipitations
CHO cells were transiently transfected with cDNA using Superfect kit
(Qiagen, Hilden, Germany) and harvested 24–36 h posttransfection. CHO
cells were washed with 10 ml ice-cold PBS and lysed with ;2 ml ice-cold
RIPA buffer (50 mM TRIS pH 7.4, 150 mM NaCl, 1 mM EDTA, 1%
IGEPAL CA-630, 0.5% (w/v) deoxycholate, 0.1% (w/v) SDS, freshly added
10 mM iodoacetamide, phosphatase and protease inhibitors (Calbiochem,
San Diego, CA; Roche, Nutley, NJ)) for 30 min at 4C. Lysates were divided
into two equal samples: one for coimmunoprecipitation experiments and one
to evaluate total protein expression. Cell lysates were centrifuged for 30 min
at 4C, and the supernatant was mixed with HA-conjugated beads (Roche)
and rocked at 4C for 3 h. Beads were washed three times with RIPA buffer
and incubated in SDS sample buffer at ;90–95C for 10 min. For coim-
munoprecipitation, cells were lysed with 1% NP-40 buffer, 50 mM TRIS
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% IGEPAL CA-630, phosphatase
and protease inhibitors (Calbiochem). Cell lysates were centrifuged for 60
min at 4C and the supernatant mixed with HA-conjugated beads (Roche)
and rocked at 4C for 3 hr. Beads were washed three times with ice-cold 1%
NP-40 buffer and then incubated in SDS sample buffer at ;90–95C for
15 min. Visualization was by monoclonal anti-HA (Roche) or anti-c-Myc
antibodies from Roche.
Membrane biotinylation
Thirty hours after transfection CHO cells were washed three times with ice-
cold PBS, and cell surface proteins were biotinylated by 1.0 mg/ml
impermeant biotin analog EZ-link sulfo-NHS-Lcbiotin (Pierce, Rockford,
IL) in PBS. After incubation at 4C for 1 h, cells were washed three times
with ice-cold PBS plus 100 mM glycine to remove any remaining bio-
tinylation reagent. Cells were then harvested in RIPA buffer. Lysate proteins
were precipitated by (SA)-linked steptoavidin agarose beads and detected by
anti-c-Myc antibodies.
Immunocytochemistry
Unpermeabilized cells. Transiently transfected cells were incubated in
fresh complete media with anti-HA or anti-c-Myc antibody (40 mg/ml) at
37C for 1 h. Cells were washed three times with PBS and ﬁxed with
paraformaldehyde (4% in PBS) for 15 min at room temperature. After ﬁxing,
cells were washed three times for 5 min with PBS and blocked for 1 h at
room temperature with 5% nonfat dry milk in PBS plus 0.1% Tween 20.
Cells were incubated with the secondary antibody, Cy3-conjugated goat
antimouse (Jackson ImmunoResearch, West Grove, PA) (1:2000, in 5%
nonfat dry milk in PBS plus 0.1% Tween 20), for 1 h at room temperature
and subsequently washed three times for 5 min with PBS.
Permeabilized cells. Transiently transfected cells were washed three
times for 5 min with PBS and ﬁxed with paraformaldehyde (4% in PBS) for
15 min at room temperature. After ﬁxing, cells were permeabilized with
0.1% Triton-100X for 5 min at room temperature. Cells were washed with
PBS and blocked for 1 h at room temperature with 5% nonfat dry milk in
PBS plus 0.1% Tween 20. Cells were incubated in fresh complete media
with anti-HA or anti-c-Myc antibody (40 mg/ml) at room temperature for
1 h. Cells were washed with PBS and were incubated with the secondary
antibody, Cy3-conjugated goat antimouse, for 1 h at room temperature and
subsequently washed three times for 5 min with PBS.
Cells were analyzed with a Zeiss LSM 510 META confocal microscope.
Electrophysiology
Data were recorded with an ampliﬁer, Axopatch 200B (Molecular Devices,
Sunnyvale, CA), a PC (Dell, Round Rock, TX), and Clampex software
(Axon). Data were ﬁltered at fc ¼ 1 kHz and sampled at 2.5 kHz. Bath
solution was (in mM): 4 KCl, 100 NaCl, 10 Hepes (pH ¼ 7.5 with NaOH),
1.8 CaCl2, and 1.0 MgCl2. Pipette solution: 100 KCl, 10 Hepes (pH ¼ 7.5
with KOH), 1.0 MgCl2, 1.0 CaCl2, 10 EGTA (pH¼ 7.5 with KOH). Whole-
cell currents were evoked by 0.1-s voltage sweeps from a holding potential
of 80 mV to 1120 mV in 20-mV increments.
Construction of transgenic animals expressing wt mps-1
and mps-1-Q
To obtain transgenic nematodes expressing GFP tagged mps-1 and mps-1-q,
the reporter constructs were injected with the transformation marker rol6(1)
and mock DNA into the syncytial gonad of adult hermaphrodite mps-1 KO
nematodes at the concentration of 20 ng/ml, 50 ng/ml, and 30 ng/ml,
respectively. Three transgenic lines carrying extrachromosomal arrays were
identiﬁed for each construct. Worms were analyzed and photographed with
an Olympus BX61 microscope equipped with a digital camera.
RESULTS
To investigate the mechanisms that determine the assembly
of MPS-1 with KVS-1, we constructed a succession of
MPS-1 truncation mutants (summarized in the cartoon in
Fig. 1 A), cotransfected them with KVS-1 in CHO cells, and
evaluated complex formation by coimmunoprecipitation.
Protein expression and trafﬁcking to the plasma membrane
of the mutants, transfected alone and cotransfected with
KVS-1, were also assessed. MPS-1 and KVS-1 were epitope
tagged in either the N- (only MPS-1) or C-terminus (both
KVS-1 and MPS-1) with the hemagluttinin (HA) and/or the
c-Myc epitope tags. Epitope tagging did not alter KVS-1 or
MPS-1 functional characteristics (data not shown).
The TMD of MPS-1 mediates assembly with KVS-1
Fig. 1 B shows that KVS-1 and wild-type (wt) MPS-1 (sim-
ply termed MPS-1 if not otherwise stated) coimmunoprecip-
itated in CHO cells, as expected. MPS-1 could be detected
into two separable bands: one running at ;31 kDa (the pre-
dicted molecular mass of MPS-1 including the epitope tag)
and one running at ;35 kDa. The upper band may reﬂect
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some posttranslational modiﬁcation such as N-glycosylation
(there is a consensus site in the N-terminus) or, alternatively,
phosphorylation, possibly self-phosphorylation, and it was
not investigated further. We ﬁrst examined whether the
N-terminus of MPS-1 had a role in the mechanisms of inter-
action. Progressive deletion of the whole domain (M1-DN)
did not impair the ability of MPS-1 to pair with KVS-1 (Fig.
1 B). Similarly, when the whole C-terminus of MPS-1 was
deleted (M1-DC, Fig. 1 B), KVS-1 and the mutant also
coimmunoprecipitated (Fig. 1 B). The TMD alone (ﬂanked
by two extramembranous domains to a ﬁnal ;10 kDa mo-
lecular mass to ensure a minimal cDNA length for protein
expression; M1-TM in Fig. 1 A) coimmunoprecipitated with
KVS-1 (Fig. 1 B). Furthermore, disruption of the TMD
obtained by inserting a stop codon in its middle gave rise to a
proteolytically unstable protein that failed to assemble with
KVS-1 or to trafﬁc to the membrane (data not shown). The
efﬁciency of complex formation varied to a considerable
extent with different mutants. Densitometry analysis showed
that partial or complete deletion of the C-terminus (M1-TM
retained about one-third of C-terminal residues) decreased
assembly efﬁciency by ;35% (Fig. 1 C).
Normal trafﬁcking of MPS-1 truncation mutants
to the plasma membrane
Expression at the plasma membrane of wt and truncation
mutants, alone or with KVS-1, was assessed by means of
membrane biotinylation and immunocytochemistry. Using a
membrane-impermeable biotin analog, we found that MPS-1
and the mutant proteins were present at comparable levels in
the plasma membrane, suggesting that the deletions did not
affect trafﬁcking (Fig. 2 A, MPS-1 and the mutants were
transfected alone. Controls were performed with tubulin and
with unbiotinylated cell transfected with MPS-1) (Fig. 2,
inset). Epitope tagging in the N-terminus allowed to perform
immunocytochemical visualizations without membrane per-
meabilization. Cells expressing MPS-1 as well the truncation
mutants exhibited a characteristic ﬂuorescent ring along the
cell boundaries indicating not only that the mutants could
reach the plasma membrane normally, in agreement with
biotinylation data, but also that their orientation was normal
(Fig. 2 B. MPS-1 and the mutants were cotransfected with
KVS-1). Moreover, cells transfected with mock DNA did not
produce any ﬂuorescence (data not shown).
Taken together, these data support the notion that the
TMD of MPS-1 is necessary and sufﬁcient for coassembly
with KVS-1. The cytoplasmic domain may also contribute but
is not necessary. In the following experiments, we focus on
the role of the TMD in the mechanisms underlying MPS-1-
KVS-1 complex formation.
Complex formation depends on the hydropathicity
of the TMD of MPS-1
Close inspection of the sequence of the transmembrane span
of MPS-1 (Fig. 3 A), the KCNE proteins, and the TMDs of
several Kv channels including KVS-1 reveals that, in
addition to hydrophobic residues, they contain several polar
and/or charged residues. These exert a destabilizing effect on
a protein embedded in the membrane because of the low
dielectric constant (e  2) of the lipid. A quantitative mea-
sure of the stability of a protein in a lipid membrane is given
by the grand average of hydropathicity (GRAVY) coefﬁ-
cient. A large GRAVY coefﬁcient indicates a highly hydro-
phobic peptide. Table 1 lists GRAVY coefﬁcients calculated
FIGURE 1 The TMD of MPS-1 is necessary and
sufﬁcient for KVS-1-MPS-1 complex assembly. (A)
Cartoon showing the panel of MPS-1 truncation mu-
tants that were generated. (B) Coimmunoprecipitations
(co-IP) and total protein expression (lysate gels) of
KVS-1-HA and MPS-1 or the indicated truncation
mutants tagged to the c-Myc epitope tag. Lysates were
divided into two equal parts: one for co-IP experi-
ments, one to evaluate protein expression. For co-IP
lysates were immunoprecipitated by HA-conjugated
beads, separated in SDS PAGE (13.5%), and Western
blotted with mouse anti-c-Myc antibody and a horse-
radish peroxidase chemiluminescence-coupled second-
ary antibody. For protein expression lysates were
Western blotted and visualized by anti-c-Myc antibody
as described. (C) Densitometry analysis of assembly
efﬁciency of MPS-1 and the indicated mutants. As-
sembly efﬁciency was calculated by normalizing band
intensity in the co-IP gel to the intensity in the lysate.
Data are presented normalized to the assembly efﬁ-
ciency of wt. Band intensities were calculated using
ImageJ software available at: http://rsb.info.nih.gov/
nih-image/Default.html. Number of determinations n ¼ 4, 5, 4, and 2, respectively, for wt, M1-DN, M1-DC, and M1-TM. Data are presented as means6 SE.
Statistically signiﬁcant differences from control (ANOVA single-factor) are indicated with, respectively, *p , 0.03 and **p , 0.0001.
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for the TMDs of KVS-1 (named from S1 to S6) and of MPS-
1. Human KCNE proteins have GRAVY coefﬁcients that
range from 1.735 of KCNE1 to 2.255 of KCNE4. This
argues that there must be a functional, as well as a structural,
need to accommodate polar/charged residues in the TMDs of
these proteins. We hypothesized that the presence of residues
acting to lower the stability of the TMD might promote
TMD-TMD interactions. The rationale for this idea is that the
TMD might increase its stability by being surrounded by
other proteins rather than lipids. To test this model, we
generated a panel of M1-DC mutants in which polar residues
were progressively replaced with aliphatic amino acids
lacking the polar group but conserving the original three-
dimensional structure (serine to alanine and threonine to
valine. The tyrosine was mutated to isoleucine; Table 1).
Mutation of a single residue (Y47I, T48V, S50A, and S56A)
or combinations of two mutations (T48V-S56A, indicated by
M1-DC-D1 in Fig. 3 B and S50A-S56A (not shown)) did not
signiﬁcantly affect the ability of M1-DC to assemble with
KVS-1. In contrast, mutation of three residues, in different
combinations, strongly decreased the efﬁciency of M1-DC-
KVS-1 complex formation (Y47I-T48V-S56A or T48V-
S50A-S56A, respectively indicated by M1-DC-T1 in Fig.
3 C and M1-DC-T2 (not shown)). As expected, coassembly
was not observed when all four polar residues were mutated
(M1-DC-Q, Fig. 3 C). In addition, an M1-DC mutant con-
structed by replacing aliphatic residues in the TMD without
signiﬁcantly altering the GRAVY coefﬁcient (mutation of
the ILI triplet to LIL) assembled normally with KVS-1 (data
not shown). Biotinylation assays (Fig. 3 D) showed that the
FIGURE 2 Normal trafﬁcking of MPS-1 truncation mu-
tants. (A) Surface expression of MPS-1 and the indicated
truncation mutants expressed in CHO cells. Mock-transfected
cells are indicated with Cnt. Cells were biotinylated with a
membrane-impermeant biotin analog and were visualized
by a monoclonal antibody to c-Myc. (Inset) Controls with
tubulin and with unbiotinylated cells transfected with
MPS-1. For ﬂuorography, chemiluminescence was per-
formed with a secondary antibody coupled to horseradish
peroxidase. (B) Immunolocalization of wt and the indicated
MPS-1 truncation mutants at the cell surface. A c-Myc
epitope fused to the N terminus was used for immunolo-
calization. (Left) Immunoﬂuorescence images of unper-
meabilized CHO cells transfected with KVS-1 and the
indicated MPS-1 variants. (Right) Phase-contrast light
transmission image of the same ﬁelds.
FIGURE 3 Neutralization of polar residues disrupts
TMD-TMD interactions. (A) Primary sequence of the
TMD of MPS-1 with polar residues in red color. (B)
Coimmunoprecipitation and protein expression of M1-DC
and the indicated mutants. The control lane (Cnt.) corre-
sponds to CHO cells transfected with M1-DC alone.
Western blot visualizations as before. (C) Coimmunopre-
cipitation and protein expression of a triple (M1-DC-T1,
T48V-S50A-S56A) and quadruple (M1-DC-Q, Y47I-
T48V-S50A-S56A) M1-DC mutant. Although the levels
of protein expression of the mutants were normal, the
mutants failed to coimmunoprecipitate with KVS-1. (D)
Surface expression of wtMPS-1, M1-DC-T1, and M1-DC-
Q mutants (cotransfected with KVS-1) assessed by the
means of membrane biotinylation as done before. In all
cases the ratio of protein in the biotinylation versus lysate
gel is 1:10. (E) Cytoplasmic distribution of wt MPS-1 and
M1-DC-Q in permeabilized CHO cells.
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M1-DC mutants exhibited normal levels of expression to the
plasma membrane. Thus, the fraction of protein that was
detected at the plasma membrane was 11 6 1% for MPS-1,
136 1% for M1-DC (not shown), and 96 1% for M1-DC-Q
(Fig. 3D, n¼ 3 in all cases) of the total protein (the lysates in
the ﬁgure were diluted 1:10). Immunocytochemical assays
did not reveal any apparent abnormality in the cytoplasmic
distribution of the proteins. Thus, replacement of the polar
residues in the TMD of M1-DC did not give rise to
proteolytically unstable proteins that could have failed to
coassemble with KVS-1 because of defective trafﬁcking to
the plasma membrane, folding, or retention in some intra-
cellular compartment.
Impaired complex formation in hydropathic
M1-DC mutants
To further test the role of hydropathicity in TMD-TMD
interactions and to exclude effects resulting from variable
antibody efﬁciency, we directly compared the ability of
MPS-1 and polar mutants to assemble with KVS-1. For this
purpose, we used M1-DN and M1-DC, which by virtue of
their different molecular masses could be tagged to the same
epitope tag and detected by the same antibody on the same
Western blot. Fig. 4 shows that when M1-DC and M1-DN,
which are both tagged to the c-Myc tag in the N-terminus,
were cotransfected with KVS-1, they both assembled with
the channel. In contrast, when the three polar residues in the
transmembrane span of M1-DC were mutated (M1-DC–T1
in Fig. 4), complex formation was strongly hindered, even
though the amount of mutant protein was larger than that of
M1-DN.
Lowering MPS-3 hydrophobicity increases
assembly efﬁciency
It is interesting to observe that MPS-3 exhibits the lowest
number of polar residues in the transmembrane span (a single
serine at position 43) and, consequently, MPS-3 has the
largest GRAVY coefﬁcient (3.27). Therefore, MPS-3 repre-
sented a good tool to test how hydropathicity correlated with
coassembly. Notably, MPS-3 coimmunoprecipitated with
KVS-1 less efﬁciently than MPS-1 (Fig. 5. normalized efﬁ-
ciency ¼ 0.35 6 0.08, n ¼ 3). Lowering the hydrophobicity
of MPS-3 by introducing a double YT mutation in the cor-
responding position (F25Y-I26T, GRAVY ¼ 2.7) increased
the assembly efﬁciency of MPS-3 to 0.53 6 0.04 (n ¼ 3)
(Fig. 5). Notwithstanding the differences in the secondary
structures of the two b-subunits, which may be responsible
for their different afﬁnities for KVS-1, these data further
strengthen the notion that a decrease in the hydrophobicity of
the TMD favors the interaction with KVS-1.
M1-DC hydropathic mutants do not assemble with
human Kv4.2
Physiological partners of MPS-1 other than KVS-1 are
presently not identiﬁed. Thus, to ascertain if and to what
TABLE 1 GRAVY coefﬁcients
MPS-1
Wt 2.026 T48V-S50A 2.352
Y47I 2.278 S50A-S56A 2.252
T48V 2.239 T48V-S50A-S56A (T2) 2.465
S50A 2.352 Y47I-T48V-S56A (T1) 2.604
S56A 2.139 Y47I-T48V-S50A-S56A (Q) 2.717
KVS-1
S1 1.878 S4 1.365
S2 1.292 S5 1.613
S3 1.83 S6 2.261
Secondary structure predictions of membrane proteins were calculated using
SOSUI software available at http://bp.nuap.nagoya-u.ac.jp/sosui/sosui_
submit.html. Grand average of hydropathicity (GRAVY) coefﬁcients of
the TMDs of MPS-1 and KVS-1 were calculated using ProtParam software
available at http://www.expasy.org/cgi-bin/protparam. FIGURE 4 M1-DC but not M1-DC-T1 coimmunoprecipitate with KVS-1.
Coimmunoprecipitations of KVS-1 with M1-DN andM1-DC or M1-DN and
M1-DC-T1. CHO cells were transfected with M1-DN and M1-DC cDNA in
a 1:1 or 1:3 ratio.
FIGURE 5 Lowering MPS-3 hydrophobicity increases assembly efﬁ-
ciency. (A) Representative Western blots of coimmunoprecipitations of wt
MPS-3 and a F25Y-I26TMPS-3mutant with KVS-1. (Bottom) Total lysates.
(B) Densitometry analysis of normalized assembly efﬁciency (to wtMPS-1)
of wtMPS-3 (wtM3, n ¼ 3) and F25Y-I26T MPS-3 (F25Y-I26T, n ¼ 3).
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extent the polar mechanism was general or speciﬁc to the
MPS-1-KVS-1 complex, we employed human Kv4.2, which
we showed previously interacts with MPS-1 (2). As ex-
pected, wt MPS-1 or M1-DC coimmunoprecipitated with
hKv4.2 (Fig. 6). In contrast, the M1-DC-T1 mutant failed to
coimmunoprecipitate even though it was abundantly ex-
pressed (Fig. 6).
Taken together, these data support two major conclusions.
First, the hydropathicity of the TMD is an important factor
controlling the assembly of MPS proteins with pore-forming
subunits as increasing the GRAVY coefﬁcient decreases
assembly efﬁciency whereas adding polar residues enhances
it. Second, the hydropathic mechanism is a general means of
interaction that appears to control the interaction of the TMD
of MPS-1 with diverse a-subunits.
The hydropathic mechanism controls wt
MPS-1 interactions
We next estimated the incidence of hydropathic forces in the
mechanisms determining the interactions of wt MPS-1. Mu-
tation of the four polar residues (M1-Q) decreased the as-
sembly efﬁciency by more than 50% (Fig. 7, A and B). To
directly compare the ability of wt and M1-Q to pair with
KVS-1, we coexpressed them in CHO cells and character-
ized the currents using electrophysiology. Currents expressed
in cells that were cotransfected with KVS-1 and M1-Q were
indistinguishable from currents in cells transfected with
KVS-1 alone (Fig. 7, C–E). In contrast, when MPS-1 was
added to the cDNA mixture (in a 1:3 ratio with M1-Q), the
currents were smaller and inactivated faster, two typical
effects of MPS-1 on the current of KVS-1 (Fig. 7, B–D) (2).
We have shown previously that, in the native cells, where
both MPS-1 and KVS-1 proteins colocalize, the expression/
stability of one depends on the other and vice versa (2). To
test whether the M1-Q mutant fails to assemble with en-
dogenous KVS-1 in living worms, we constructed transgenic
animals expressing wt and M1-Q fused to GFP in the
C-terminus in an mps-1 knockout (KO) background. These
animals are indicated by, respectively, VC955(wt) and
VC955(m1-q) in Fig. 7 F. As expected, animals expressing
mps-1::gfp exhibited normal expression (arrow). In contrast,
the animals expressing m1-q::gfp displayed faint ﬂuores-
cence. Because GFP requires high levels of protein to give
detectable signals, these data suggest that the amount of
MPS-1 protein at the membrane was decreased in the trans-
genic animals as a result of impaired complex formation with
KVS-1. We conclude that the hydropathic mechanism con-
tributes to MPS-1-KVS-1 complex formation in vivo.
DISCUSSION
Here we investigate the molecular mechanisms governing
the assembly of MPS-1 with Kv a-subunits. Biochemical
and electrophysiological analyses support the following
conclusions. First, MPS-1 can form stable complexes with
physiological channel partner KVS-1 and also with evolu-
tionarily distant channels such as human Kv4.2. Second, the
TMD is necessary and sufﬁcient for complex formation. The
C-terminus can also promote assembly through mechanisms
that are poorly understood at present. Third, the hydro-
pathicity of the TMD is a key factor for assembly. Neu-
tralization of polar residues hindered MPS-1’s ability to
assemble with KVS-1 and hKv4.2. MPS-3, which is the most
hydrophobic member in the family, interacted with KVS-1
less efﬁciently than MPS-1. Notably, the assembly efﬁciency
of MPS-3 could be enhanced by lowering the hydrophobicity
of its TMD by mutating the two aliphatic residues FI to YT.
It is also interesting to note that MPS-3 cannot form binary
complexes with KVS-1 in vivo. However, MPS-3 can part-
ner with KVS-1 when a second MPS protein is present,
giving rise to ternary complexes containing two distinct MPS
subunits (7). It was imperative for us to ascertain that re-
placement of multiple polar residues in the transmembrane
span of MPS-1 did not give rise to proteotically unstable
proteins. The mutants exhibited normal cytoplasmic distri-
bution, trafﬁcking, orientation, and abundance in the plasma
membrane. In fact, they partially retained the ability to as-
semble with the a-subunit.
Polar residues have been shown to promote strong TMD-
TMD interactions by establishing hydrogen bonds (15–22).
Dawson and colleagues screened a randomized library of
transmembrane interfaces and identiﬁed two common mo-
tifs: SxxSSxxT and SxxxSSxxT (16). Mutations of single
serines or threonines in these motifs completely abolished
TMD-TMD interactions, indicating that the contact between
these positions is very speciﬁc. MPS-1 and other KCNE
FIGURE 6 M1-DC but not M1-DC-T1 assembles with human Kv4.2.
Coimmunoprecipitations and total lysates of hKv4.2 tagged to the HA
epitope tag in the C-terminus with wt MPS-1, M1-DC, and M1-DC-T1.
Lysates were immunoprecipitated by HA-conjugated beads and visualized
by anti-c-Myc antibody as before.
3088 Wang and Sesti
Biophysical Journal 93(9) 3083–3091
proteins interact with multiple channels; thus, it would be
difﬁcult, if not impossible, to achieve spatial correspondence
in these varied conditions. The hydropathicity of the trans-
membrane span, rather than speciﬁc polar residues, may
be an important factor for the assembly of MPS-1 with
a-subunits. Unlike the peptides considered by Dawson, neu-
tralization of one or two polar residues did not impair the
ability of MPS-1 to partner with KVS-1. This suggests two
characteristics of MPS-1 interactions with Kv a-subunits.
First, spatial correspondence of polar residues is not a re-
quirement. Second, lack of coassembly was not likely caused
by structural rearrangements in the TMD because single or
double mutations did not hinder pairing. Polar residues exert
a destabilizing effect on a protein embedded in the mem-
brane because of the low dielectric constant of the lipid. This
argues that there must be a functional as well as a structural
need to accommodate these residues. We propose that the
need to minimize the electrostatic energy generated by polar
residues embedded in the membrane is a primary force
behind MPS-1 assembly because surrounding MPS-1 with
proteins rather than lipids would decrease the electrostatic
energy. This mechanism does not require speciﬁc points of
contact between TMDs, and as a result, it is consistent with
the natural promiscuity of MPS-1 and the other KCNE
FIGURE 7 Increased hydropathicity in the TMD of wtMPS-1 decreases assembly efﬁciency. (A) Coimmunoprecipitations and total lysates of KVS-1 with
wt MPS-1 or MPS-1-Q (M1-Q). (B) Densitometry analysis of assembly efﬁciency of the mutant (n ¼ 9). The symbol ** indicates a statistically signiﬁcant
difference from control (p , 0.02). (C) Whole-cell currents elicited by voltage jumps from 80 mV to 1120 mV in 20-mV increments and 1-s interpulse
intervals in cells transfected with KVS-1 alone (KVS-1), M1-Q and KVS-1 (K11M1-Q), and KVS-1 and MPS-1 and M1-Q in a 1:3 ratio (K11M11M1-Q).
(D) Inactivation rates for currents recorded in cells transfected with KVS-1 alone (squares), M1-Q 1 KVS-1 (circles), or MPS-11 M1-Q 1 KVS-1
(triangles). Time constants were obtained by ﬁtting macroscopic currents to a single-exponential function: Io1 I1exp(t/t). Data are from groups of 10 cells.
(E) Macroscopic current densities calculated by normalizing the peak current at1120 mV to the cell capacitance in cells transfected with KVS-1 alone, M1-Q1
KVS-1, or MPS-11M1-Q1 KVS-1. Averages were computed from groups of 10–15 cells. (F) Fluorescence microscopy images taken from VC955(wt) and
VC955(m1-q) transgenic nematode heads. In these focal planes GFP ﬂuorescence (arrows) is detectable in amphid neurons. Fluorescence in the intestine is
caused by endogenous rhabditin granules. Error bars represent SE. Signiﬁcant differences from control (p , 0.05) are indicated with *.
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proteins. It is also worth considering that ion channels
contain several polar/charged residues in their TMDs, which
might facilitate MPS-1 incorporation in the complex by the
same mechanism.
These data also reveal an unexpected complexity in the
mechanisms underlying MPS-1-KVS-1 complex formation.
The cytoplasmic domain is a site of interaction—a quanti-
tative estimate shows that this domain can rescue coassem-
bly by 40% when the hydrophilic mechanism is neutralized.
Studies with other KCNE proteins point toward a role of this
domain in controlling the attributes of such complexes (23–
26). This implies that the cytoplasmic domain of KCNE
proteins may favor and/or stabilize assembly. The potential
role of hydrophobic interactions needs to be elucidated.
These are mediated by short-range van der Waals forces (15)
that may become particularly effective once the b-subunit is
incorporated in the complex. Glycine residues in the trans-
membrane spans of viral proteins, for instance, are partic-
ularly important for fusion activity (27). Thus, the fact that
MPS-1 polar mutants and MPS-3 do not assemble efﬁciently
with KVS-1 does not exclude the possibility that van der
Waals forces may provide a key contribution to the forma-
tion and/or stability of these complexes. The hydropathic
mechanism does not explain how structural speciﬁcity within
the complex is achieved. Functional and biochemical studies
indicate that the KCNE proteins occupy speciﬁc positions in
a complex even though there is controversy as to the speciﬁc
location (28–32). Further investigations will be needed to
address these important issues.
Recently it has been shown that human KCNE1 is retained
in the ER and that progression through the secretory pathway
requires coassembly with an a-subunit (33,34). On the other
hand, several studies have shown that KCNE subunits alone,
heterologously expressed in diverse cell lines, can trafﬁc to
the plasma membrane (2,35–37). Although in CHO cells
MPS-1 alone can trafﬁc to the plasma membrane, in native
cells, MPS-1 and other MPS proteins require coassembly
with an a-subunit (2,7). Here we conﬁrm this notion by
showing that MPS-1-Q mutants do not assemble with KVS-1
in vivo and, as a result, fail to be processed normally.
Therefore, the requirement for an a-subunit in heterologous
systems remains a matter of controversy.
In summary, we have identiﬁed one of the primary mech-
anisms determining MPS-1-Kv a-subunit assembly. It is
highly likely that future studies will elucidate additional
aspects of this mechanism, which appears to be remarkably
complex, and unravel the mechanisms underlying the as-
sembly of human KCNE genes that we expect will be
similar.
The mps-1 KO strain was a kind gift of the Caenorhabditis elegans Knock
Out Consortium. We thank Dr. Zui Pan for helping with the confocal
microscope, Drs. John Lenard, Shi-Qing Cai, and Noah Weisleder for
critical reading of the manuscript, and Laila Sesti for help with the graphics.
This work was supported by a National Institutes of Health grant
(R01GM68581) to F.S.
REFERENCES
1. Li, Y., S. Y. Um, and T. V. McDonald. 2006. Voltage-gated potas-
sium channels: regulation by accessory subunits. Neuroscientist. 12:
199–210.
2. Bianchi, L., S. M. Kwok, M. Driscoll, and F. Sesti. 2003. A
potassium channel-MiRP complex controls neurosensory function in
Caenorhabditis elegans. J. Biol. Chem. 278:12415–12424.
3. Cai, S. Q., L. Hernandez, Y. Wang, K. H. Park, and F. Sesti. 2005.
MPS-1 is a K1channel beta-subunit and a serine/threonine kinase. Nat.
Neurosci. 8:1503–1509.
4. Abbott, G. W., F. Sesti, I. Splawski, M. E. Buck, M. H. Lehmann,
K. W. Timothy, M. T. Keating, and S. A. Goldstein. 1999. MiRP1
forms IKr potassium channels with HERG and is associated with
cardiac arrhythmia. Cell. 97:175–187.
5. Anantharam, A., A. Lewis, G. Panaghie, E. Gordon, Z. A. McCrossan,
D. J. Lerner, and G. W. Abbott. 2003. RNA interference reveals that
endogenous Xenopus MinK-related peptides govern mammalian K1
channel function in oocyte expression studies. J. Biol. Chem. 278:
11739–11745.
6. Takumi, T., H. Ohkubo, and S. Nakanishi. 1988. Cloning of a mem-
brane protein that induces a slow voltage-gated potassium current.
Science. 242:1042–1045.
7. Park, K. H., L. Hernandez, S. Q. Cai, Y. Wang, and F. Sesti. 2005. A
family of K1 channel ancillary subunits regulate taste sensitivity in
Caenorhabditis elegans. J. Biol. Chem. 280:21893–21899.
8. Abbott, G., M. H. Butler, S. Bendahhou, M. C. Dalakas, I. J. Ptacek,
and S. A. Goldstein. 2001. MiRP2 forms potassium channels in
skeletal muscle with Kv3.4 and is associated with periodic paralysis.
Cell. 104:217–231.
9. Duggal, P., M. R. Vesely, D. Wattanasirichaigoon, J. Villafane,
V. Kaushik, and A. H. Beggs. 1998. Mutation of the gene for IsK
associated with both Jervell and Lange-Nielsen and Romano-Ward
forms of Long-QT syndrome. Circulation. 97:142–146.
10. Schulze-Bahr, E., Q. Wang, H. Wedekind, W. Haverkamp, Q. Chen,
Y. Sun, C. Rubie, M. Ho¨rdt, J. A. Towbin, M. Borggrefe, G. Assmann,
X. Qu, J. C. Somberg, G. Breithardt, C. Oberti, and H. Funke. 1997.
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat.
Genet. 17:267–268.
11. Splawski, I., M. Tristani-Firouzi, M. H. Lehmann, M. C. Sanguinetti,
and M. T. Keating. 1997. Mutations in the hMinK gene cause long QT
syndrome and suppress IKs function. Nat. Genet. 17:338–340.
12. McCrossan, Z. A., and G. W. Abbott. 2004. The MinK-related pep-
tides. Neuropharmacology. 47:787–821.
13. Cai, S. Q., K. H. Park, and F. Sesti. 2006. An evolutionarily conserved
family of accessory subunits of K1 channels. Cell Biochem. Biophys.
46:91–100.
14. Abbott, G. W., and S. A. Goldstein. 2002. Disease-associated muta-
tions in KCNE potassium channel subunits (MiRPs) reveal promiscu-
ous disruption of multiple currents and conservation of mechanism.
FASEB J. 16:390–400.
15. Curran, A. R., and D. M. Engelman. 2003. Sequence motifs, polar
interactions and conformational changes in helical membrane proteins.
Curr. Opin. Struct. Biol. 13:412–417.
16. Dawson, J. P., J. S. Weinger, and D. M. Engelman. 2002. Motifs of
serine and threonine can drive association of transmembrane helices.
J. Mol. Biol. 316:799–805.
17. Dawson, J. P., R. A. Melnyk, C. M. Deber, and D. M. Engelman. 2003.
Sequence context strongly modulates association of polar residues in
transmembrane helices. J. Mol. Biol. 331:255–262.
18. Feng, J., M. E. Call, and K. W. Wucherpfennig. 2006. The assembly of
diverse immune receptors is focused on a polar membrane-embedded
interaction site. PLoS Biol. 4:e142.
19. Garrity, D., M. E. Call, J. Feng, and K. W. Wucherpfennig. 2005. The
activating NKG2D receptor assembles in the membrane with two
signaling dimers into a hexameric structure. Proc. Natl. Acad. Sci.
USA. 102:7641–7646.
3090 Wang and Sesti
Biophysical Journal 93(9) 3083–3091
20. Adamian, L., and J. Liang. 2002. Interhelical hydrogen bonds and
spatial motifs in membrane proteins: polar clamps and serine zippers.
Proteins. 47:209–218.
21. Adamian, L., and J. Liang. 2001. Helix-helix packing and interfacial
pairwise interactions of residues in membrane proteins. J. Mol. Biol.
311:891–907.
22. Gratkowski, H., J. D. Lear, and W. F. DeGrado. 2001. Polar side chains
drive the association of model transmembrane peptides. Proc. Natl.
Acad. Sci. USA. 98:880–885.
23. Gage, S., and W. Kobertz. 2004. KCNE3 truncation mutants reveal a
bipartite modulation of KCNQ1 K1 channels. J. Gen. Physiol. 124:
759–771.
24. Melman, Y. F., A. Krumerman, and T. V. McDonald. 2002. A single
transmembrane site in the KCNE-encoded proteins controls the spec-
iﬁcity of KvLQT1 channel gating. J. Biol. Chem. 277:25187–25194.
25. Melman, Y. F., A. Domenech, S. de la Luna, and T. V. McDonald.
2001. Structural determinants of KvLQT1 control by the KCNE family
of proteins. J. Biol. Chem. 276:6439–6444.
26. Abbott, G. W., M. H. Butler, and S. A. Goldstein. 2006. Phospho-
rylation and protonation of neighboring MiRP2 sites: function and
pathophysiology of MiRP2-Kv3.4 potassium channels in periodic
paralysis. FASEB J. 20:293–301.
27. Cleverley, D. Z., and J. Lenard. 1998. The transmembrane domain in
viral fusion: essential role for a conserved glycine residue in vesicular
stomatitis virus G protein. Proc. Natl. Acad. Sci. USA. 95:3425–3430.
28. Melman, Y. F., S. Y. Um, A. Krumerman, A. Kagan, and T. V.
McDonald. 2004. KCNE1 binds to the KCNQ1 pore to regulate
potassium channel activity. Neuron. 42:927–937.
29. Tai, K., and S. Goldstein. 1998. The conduction pore of a cardiac po-
tassium channel. Nature. 391:605–608.
30. Kurokawa, J., H. Motoike, and R. Kass. 2001. TEA(1)-sensitive
KCNQ1 constructs reveal pore-independent access to KCNE1 in
assembled I(Ks) channels. J. Gen. Physiol. 117:43–52.
31. Chen, H., F. Sesti, and S. A. Goldstein. 2003. Pore- and state-
dependent cadmium block of I(Ks) channels formed with MinK-55C
and wild-type KCNQ1 subunits. Biophys. J. 84:3679–3689.
32. Tapper, A., and A. J. George. 2000. MinK subdomains that mediate
modulation of and association with KvLQT1. J. Gen. Physiol. 116:
379–390.
33. Chandrasekhar, K. D., T. Bas, and W. R. Kobertz. 2006. KCNE1
subunits require co-assembly with K(1) channels for efﬁcient traf-
ﬁcking and cell surface expression. J. Biol. Chem. 281:40015–40023.
34. McCrossan, Z. A., A. Lewis, G. Panaghie, P. N. Jordan, D. J. Christini,
D. J. Lerner, and G. W. Abbott. 2003. MinK-related peptide 2
modulates Kv2.1 and Kv3.1 potassium channels in mammalian brain.
J. Neurosci. 23:8077–8091.
35. Bianchi, L., Z. Shen, A. T. Dennis, S. G. Priori, C. Napolitano,
E. Ronchetti, R. Bryskin, P. J. Schwartz, and A. M. Brown. 1999.
Cellular dysfunction of LQT5-MinK mutants: abnormalities of IKs, IKr
and trafﬁcking in long QT syndrome. Hum. Mol. Genet. 8:1499–1507.
36. Krumerman, A., X. Gao, J. S. Bian, Y. F. Melman, A. Kagan, and
T. V. McDonald. 2004. An LQT mutant minK alters KvLQT1
trafﬁcking. Am. J. Physiol. Cell Physiol. 286:C1453–1463.
37. Grunnet, M., T. Jespersen, H. B. Rasmussen, T. Ljungstrøm, N. K.
Jorgensen, S. P. Olesen, and D. A. Klaerke. 2002. KCNE4 is an
inhibitory subunit to the KCNQ1 channel. J. Physiol. 542:119–130.
Mechanisms of MPS-1-KVS-1 Channel Complex Assembly 3091
Biophysical Journal 93(9) 3083–3091
